EBiSC – the first European bank for induced pluripotent stem cells
14 February 2014 | By EBiSC
A consortium of 26 partners has been formed to establish the “European Bank for induced pluripotent Stem Cells” (EBiSC) with support from the IMI.
List view / Grid view
14 February 2014 | By EBiSC
A consortium of 26 partners has been formed to establish the “European Bank for induced pluripotent Stem Cells” (EBiSC) with support from the IMI.
11 February 2014 | By Merck
MSD and Samsung Bioepis Co., Ltd., announced that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293...
5 February 2014 | By Pfizer
Agreement to combine MSD’s investigational anti-PD-1 and key Pfizer oncology assets...
5 February 2014 | By Amgen
Amgen and MSD announced that they have entered into an agreement through a subsidiary to evaluate the safety and efficacy of talimogene laherparepvec...
4 February 2014 | By Domain Therapeutics
DTect-All(TM) platform will be used to screen for GPCR-directed allosteric modulator antibodies...